SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001144204-19-012434
Filing Date
2019-03-06
Accepted
2019-03-06 08:01:29
Documents
81
Period of Report
2018-12-31

Document Format Files

Seq Description Document Type Size
1 10-K tv514295_10k.htm 10-K 1314815
2 EXHIBIT 21.1 tv514295_ex21-1.htm EX-21.1 1759
3 EXHIBIT 23.1 tv514295_ex23-1.htm EX-23.1 3269
4 EXHIBIT 23.2 tv514295_ex23-2.htm EX-23.2 3227
5 EXHIBIT 31.1 tv514295_ex31-1.htm EX-31.1 10288
6 EXHIBIT 31.2 tv514295_ex31-2.htm EX-31.2 10286
7 EXHIBIT 32.1 tv514295_ex32-1.htm EX-32.1 3908
8 EXHIBIT 32.2 tv514295_ex32-2.htm EX-32.2 4015
9 GRAPHIC tv514734_img1.jpg GRAPHIC 63318
  Complete submission text file 0001144204-19-012434.txt   11670545

Data Files

Seq Description Document Type Size
10 XBRL INSTANCE DOCUMENT lpcn-20181231.xml EX-101.INS 4106185
11 XBRL TAXONOMY EXTENSION SCHEMA lpcn-20181231.xsd EX-101.SCH 41611
12 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE lpcn-20181231_cal.xml EX-101.CAL 50739
13 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE lpcn-20181231_def.xml EX-101.DEF 299085
14 XBRL TAXONOMY EXTENSION LABEL LINKBASE lpcn-20181231_lab.xml EX-101.LAB 353942
15 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE lpcn-20181231_pre.xml EX-101.PRE 356151
Mailing Address 675 ARAPEEN DRIVE, SUITE 202 SALT LAKE CITY X1 84108
Business Address 675 ARAPEEN DRIVE, SUITE 202 SALT LAKE CITY X1 84108 801 994 7383
Lipocine Inc. (Filer) CIK: 0001535955 (see all company filings)

IRS No.: 990370688 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36357 | Film No.: 19661287
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences